| Interactions between human mesenchymal stem cells and natural killer cells PA Sotiropoulou, SA Perez, AD Gritzapis, CN Baxevanis, M Papamichail Stem cells 24 (1), 74-85, 2006 | 1309 | 2006 |
| An improved fluorescence assay for the determination of lymphocyte-mediated cytotoxicity using flow cytometry NG Papadopoulos, GVZ Dedoussis, G Spanakos, AD Gritzapis, ... Journal of immunological methods 177 (1-2), 101-111, 1994 | 349 | 1994 |
| Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto’s thyroiditis (Th1) and Graves’ disease (Th2) C Phenekos, A Vryonidou, AD Gritzapis, CN Baxevanis, M Goula, ... Neuroimmunomodulation 11 (4), 209-213, 2004 | 261 | 2004 |
| Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients G Spanakos, CN Baxevanis, M Economou, AD Gritzapis, MP Papamichail, ... Schizophrenia research 47 (1), 13-25, 2001 | 236 | 2001 |
| Tumor-specific CD4+ T lymphocytes from cancer patients are required for optimal induction of cytotoxic T cells against the autologous tumor CN Baxevanis, IF Voutsas, OE Tsitsilonis, AD Gritzapis, R Sotiriadou, ... The Journal of Immunology 164 (7), 3902-3912, 2000 | 210 | 2000 |
| Natural killer lymphocytes: biology, development, and function M Papamichail, SA Perez, AD Gritzapis, CN Baxevanis Cancer Immunology, Immunotherapy 53, 176-186, 2004 | 190 | 2004 |
| Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine‐activated killer cell function in patients with … CN Baxevanis, GJ Reclos, AD Gritzapis, GVZ Dedousis, I Missitzis, ... cancer 72 (2), 491-501, 1993 | 161 | 1993 |
| A new era in anticancer peptide vaccines SA Perez, E von Hofe, NL Kallinteris, AD Gritzapis, GE Peoples, ... Cancer 116 (9), 2071-2080, 2010 | 130 | 2010 |
| Compromised anti‐tumor responses in tumor necrosis factor‐α knockout mice CN Baxevanis, IF Voutsas, OE Tsitsilonis, ML Tsiatas, AD Gritzapis, ... European journal of immunology 30 (7), 1957-1966, 2000 | 123 | 2000 |
| Immunogenic HER-2/neu peptides as tumor vaccines CN Baxevanis, NN Sotiriadou, AD Gritzapis, PA Sotiropoulou, SA Perez, ... Cancer Immunology, Immunotherapy 55, 85-95, 2006 | 110 | 2006 |
| Large-scale expansion of CD3+CD56+ lymphocytes capable of lysing autologous tumor cells with cytokine-rich supernatants A Gritzapis, D Dimitroulopoulos, E Paraskevas, C Baxevanis, ... Cancer Immunology, Immunotherapy 51, 440-448, 2002 | 109 | 2002 |
| In vivo antitumor activity of NKT cells activated by the combination of IL-12 and IL-18 CN Baxevanis, AD Gritzapis, M Papamichail The Journal of Immunology 171 (6), 2953-2959, 2003 | 100 | 2003 |
| A novel myeloid-like NK cell progenitor in human umbilical cord blood SA Perez, PA Sotiropoulou, DG Gkika, LG Mahaira, DK Niarchos, ... Blood, The Journal of the American Society of Hematology 101 (9), 3444-3450, 2003 | 90 | 2003 |
| CRD-BP/IMP1 expression characterizes cord blood CD34+ stem cells and affects c-myc and IGF-II expression in MCF-7 cancer cells P Ioannidis, LG Mahaira, SA Perez, AD Gritzapis, PA Sotiropoulou, ... Journal of Biological Chemistry 280 (20), 20086-20093, 2005 | 89 | 2005 |
| Peptide HER2 (776–788) represents a naturally processed broad MHC class II-restricted T cell epitope R Sotiriadou, SA Perez, AD Gritzapis, PA Sotiropoulou, H Echner, ... British Journal of Cancer 85 (10), 1527-1534, 2001 | 87 | 2001 |
| HER-2/neu as a target for cancer vaccines CN Baxevanis, IF Voutsas, AD Gritzapis, SA Perez, M Papamichail Immunotherapy 2 (2), 213-226, 2010 | 68 | 2010 |
| Vaccination with human HER-2/neu (435-443) CTL peptide induces effective antitumor immunity against HER-2/neu-expressing tumor cells in vivo AD Gritzapis, LG Mahaira, SA Perez, NT Cacoullos, M Papamichail, ... Cancer research 66 (10), 5452-5460, 2006 | 66 | 2006 |
| HER-2/neu-derived peptide 884–899 is expressed by human breast, colorectal and pancreatic adenocarcinomas and is recognized by in-vitro-induced specific CD4+ T cell clones SA Perez, PA Sotiropoulou, NN Sotiriadou, A Mamalaki, AD Gritzapis, ... Cancer Immunology, Immunotherapy 50, 615-624, 2002 | 66 | 2002 |
| A potential role for hydrocortisone in the positive regulation of IL-15–activated NK-cell proliferation and survival SA Perez, LG Mahaira, FJ Demirtzoglou, PA Sotiropoulou, P Ioannidis, ... Blood 106 (1), 158-166, 2005 | 60 | 2005 |
| HER‐2/neu–derived peptide epitopes are also recognized by cytotoxic CD3+CD56+ (natural killer T) lymphocytes CN Baxevanis, AD Gritzapis, OE Tsitsilonis, HL Katsoulas, M Papamichail International journal of cancer 98 (6), 864-872, 2002 | 60 | 2002 |
